In a press launch issued on Thursday, the federal well being company is requiring labeling modifications for nonsteroidal anti-inflammatory medication, resembling ache relievers Aleve and Advil, as a result of potential fetal kidney issues past the 20-week being pregnant mark.
Get more stuff like this
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.